SGH
BLUE

Schonfeld Group Holdings’s bluebird bio BLUE Stock Holding History

Schonfeld Group Holdings’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$201K Buy
+242
New +$242K 0.13% 220
2015
Q3 		– Sell
-494
Closed -$1.08M – 231
2015
Q2 		$1.08M Buy
+494
New +$1.01M 0.99% 27

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Schonfeld Group Holdings's BLUE Position: Q4 2015 in Review

Schonfeld Group Holdings opened a new position in bluebird bio (BLUE) in Q4 2015: 242 shares worth $201K. The stake represents 0.13% of the portfolio and ranks #220 among its holdings. This is a return to the name: Schonfeld Group Holdings previously reported a position in BLUE as recently as Q2 2015.

Schonfeld Group Holdings first reported a position in BLUE in Q2 2015 and has held it in 2 quarters since. The position peaked at $1.08M in Q2 2015. 193 funds tracked by Wall St. Rank hold BLUE as of Q4 2015.

  • Schonfeld Group Holdings held 242 shares of bluebird bio worth $201K as of Q4 2015.
  • bluebird bio was a new Schonfeld Group Holdings position in Q4 2015.
  • bluebird bio made up 0.13% of Schonfeld Group Holdings's portfolio in Q4 2015, its #220 holding.
  • Schonfeld Group Holdings first reported a position in bluebird bio in Q2 2015 and has held it in 2 quarters since.
  • Schonfeld Group Holdings's bluebird bio position peaked at $1.08M in Q2 2015.
  • 193 funds tracked by Wall St. Rank held bluebird bio as of Q4 2015.

Based on Schonfeld Group Holdings's 13F filing for Q4 2015, filed 12 Feb 2016.